Bharat Biotech’s intranasal vaccine gets approval as heterologous booster
Bharat Biotech, a global leader in vaccine innovation and developer of vaccines for infectious diseases, today announced that iNCOVACC, has received approval from the Central Drugs Standard Control Organisation (CDSCO) under Restricted Use in Emergency Situation for ages 18 and above, in India, for heterologous booster…
